CIK 0001641631 · Non-accelerated filer<br>Smaller reporting company
Beyond Air, Inc.
Sign in to watch- Ticker
- XAIR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473812456
- Phone
- 516-665-8200
- Business address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530
- Former names
- AIT Therapeutics, Inc., KokiCare, Inc.
- Open-market buys, last 90 days
- $62,352
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,352. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-22 | Forbes William P Director | Returned to the company · Stock Options (Right to buy) | −25,000 | 0 | ||
| 2024-11-22 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-11-22 | Forbes William P Director | Returned to the company · Stock Options (Right to buy) | −25,000 | 0 | ||
| 2024-11-22 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-11-22 | Forbes William P Director | Returned to the company · Stock Options (Right to buy) | −30,000 | 0 | ||
| 2024-11-22 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +30,000 | 30,000 | ||
| 2024-11-22 | Forbes William P Director | Returned to the company · Stock Options (Right to buy) | −40,000 | 0 | ||
| 2024-11-22 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +40,000 | 40,000 | ||
| 2024-11-22 | Forbes William P Director | Returned to the company · Stock Options (Right to buy) | −45,000 | 0 | ||
| 2024-11-22 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −90,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +90,000 | 90,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −40,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +40,000 | 40,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −30,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +30,000 | 30,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −25,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −25,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 |
Page 11 of 17 · 328 trades